V/v, в виде медленной одночасовой инфузии, по 400 мг каждые 12 ч.

The contents of one ampoule (400 mg) are diluted with 250 ml of 5% glucose solution.

Abactal® must not be diluted with a sodium chloride solution or any solvent containing chlorine ions. To quickly achieve an effective concentration in the blood at the beginning of treatment, you can prescribe a shock dose of 800 mg of the drug.

To prevent infections in surgery, it is recommended to administer 400-800 mg of pefloxacin 1 hour before surgery.

In elderly patients, especially with concomitant renal impairment, the dose should be reduced.

In the case of liver disease, 8 mg/kg is prescribed as an infusion for 1 hour:

- 1 time a day (jaundice)

- every 36 hours (ascites)

- every 48 hours (jaundice and ascites).

The maximum daily dose is 1200 mg.

• Antimicrobial agent, fluoroquinolone [Quinolones/Fluoroquinolones]

In a place protected from light, at a temperature not exceeding 25 °C.

Keep out of reach of children.

Do not use after the expiration date indicated on the package.

Concentrate for the preparation of a solution for intravenous administration, 80 mg / ml. По 5 мл концентрата для приготовления раствора для в/в введения в ампуле; по 10 амп. в поддоне, по 1 поддону в пачке картонной.

According to the recipe.

J01MA03 of Pefloxacin

• A00 Cholera
• A01 Typhus and paratyphoid
• A01. 1 Paratyph A
• A01. 2 Paratyph B
• A01. 3 Paratyph C
• A02 Other salmonella infections
• A03 Shigellosis
• A04. 0 Enteropathogenic infection caused by Escherichia coli
• A28. 2 Extraintestinal yersiniosis
• A39. 0 Meningococcal meningitis
• A54 Gonococcal infection
• A56 Other sexually transmitted chlamydia diseases
• D84. 9 Immunodeficiency, unspecified
• G00 Bacterial meningitis, not classified elsewhere
• G00. 9 Bacterial meningitis, unspecified
• G03. 9 Meningitis, unspecified
• H70 Mastoiditis and related conditions
• I33. 0 Acute and subacute infectious endocarditis
• J01 Acute sinusitis
• J06 Acute upper respiratory tract infections of multiple and unspecified localization
• J18 Pneumonia without specifying the causative agent
• J20 Acute bronchitis
• J22 Acute respiratory infection of the lower respiratory tract, unspecified
• J32 Chronic sinusitis
• J42 Chronic bronchitis, unspecified
• J47 Bronchiectatic disease [bronchiectasis]
• K65 Peritonitis
• K65. 8 Other types of peritonitis
• K81 Cholecystitis
• K83. 0 Cholangitis
• K85 Acute pancreatitis
• K86. 1 Other chronic pancreatitis
• L08. 9 Local infection of the skin and subcutaneous tissue, unspecified
• L98. 9 Skin and subcutaneous tissue damage, unspecified
• M00. 9 Pyogenic arthritis, unspecified (infectious)
• M79. 8 Other specified soft tissue lesions
• M86 Osteomyelitis
• M89. 9 Bone disease, unspecified
• N10 Acute tubulointerstitial nephritis
• N11 Chronic tubulointerstitial nephritis
• N12 Tubulointerstitial nephritis, not specified as acute or chronic
• N39. 0 Urinary tract infection without established localization
• N41 Inflammatory diseases of the prostate gland
• N45 Orchitis and epididymitis
• N45. 9 Orchitis, epididymitis and epididymo-orchitis without mention of abscess
• N49 Inflammatory diseases of the male genitals, not classified elsewhere
• N70 Salpingitis and oophoritis
• N71 Inflammatory diseases of the uterus, other than the cervix
• N73. 5 Pelvic peritonitis in women, unspecified
• N74. 3 Gonococcal inflammatory diseases of the female pelvic organs (A54. 2 )
• N75 Diseases of the bartholin gland
• O85 Postpartum sepsis
• Z100* CLASS XXII Surgical Practice
• Z98. 8 Other specified post-surgical conditions